Voloridge Investment Management’s Cellebrite CLBT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-701,919
Closed -$11.2M 1209
2025
Q2
$11.2M Buy
701,919
+117,146
+20% +$2.09M 0.04% 514
2025
Q1
$11.4M Sell
584,773
-198,917
-25% -$4.19M 0.04% 529
2024
Q4
$17.3M Sell
783,690
-186,075
-19% -$3.58M 0.06% 396
2024
Q3
$16.3M Buy
969,765
+250,202
+35% +$3.71M 0.06% 435
2024
Q2
$8.6M Sell
719,563
-32,451
-4% -$363K 0.03% 603
2024
Q1
$8.33M Buy
752,014
+721,917
+2,399% +$7.37M 0.03% 529
2023
Q4
$261K Buy
+30,097
New +$234K ﹤0.01% 1089

Other funds holding CLBT

Voloridge Investment Management's CLBT Position: Q3 2025 in Review

Voloridge Investment Management sold out of Cellebrite (CLBT) in Q3 2025, closing a stake of 701,919 shares — an estimated $11.2M sold.

Voloridge Investment Management first reported a position in CLBT in Q4 2023 and held it in 7 quarters. The position peaked at $17.3M in Q4 2024. 197 funds tracked by Wall St. Rank hold CLBT as of Q3 2025.

  • Voloridge Investment Management reported no remaining Cellebrite position as of Q3 2025 after selling out during the quarter.
  • Voloridge Investment Management sold 701,919 Cellebrite shares in Q3 2025, an estimated $11.2M.
  • Voloridge Investment Management first reported a position in Cellebrite in Q4 2023 and held it in 7 quarters.
  • Voloridge Investment Management's Cellebrite position peaked at $17.3M in Q4 2024.
  • 197 funds tracked by Wall St. Rank held Cellebrite as of Q3 2025.

Based on Voloridge Investment Management's 13F filing for Q3 2025, filed 14 Nov 2025.